Publications:

Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemia.

Oncotarget

Lim, Ken-Hong KH; Chen, Caleb Gon-Shen CG; Chang, Yu-Cheng YC; Chiang, Yi-Hao YH; Kao, Chen-Wei CW; Wang, Wei-Ting WT; Chang, Chiao-Yi CY; Huang, Ling L; Lin, Ching-Sung CS; Cheng, Chun-Chia CC; Cheng, Hung-I HI; Su, Nai-Wen NW; Lin, Johnson J; Chang, Yi-Fang YF; Chang, Ming-Chih MC; Hsieh, Ruey-Kuen RK; Lin, Huan-Chau HC; Kuo, Yuan-Yeh YY

Publication Date: 2017-05-16

Variant appearance in text: CALR: E380X

PubMed Link: 28415571

Variant Present in the following documents:

• Main text

View BVdb publication page

CALR mutation characterization in myeloproliferative neoplasms.

Oncotarget

Bilbao-Sieyro, Cristina C; Florido, Yanira Y; Gómez-Casares, María Teresa MT

Publication Date: 2016-08-16

Variant appearance in text: CALR: E380X

PubMed Link: 27384487

Variant Present in the following documents:

• Main text
• oncotarget-07-52614.pdf

View BVdb publication page

Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis.

Blood Cancer Journal

Lim, K-H KH; Chang, Y-C YC; Gon-Shen Chen, C C; Lin, H-C HC; Wang, W-T WT; Chiang, Y-H YH; Cheng, H-I HI; Su, N-W NW; Lin, J J; Chang, Y-F YF; Chang, M-C MC; Hsieh, R-K RK; Kuo, Y-Y YY; Chou, W-C WC

Publication Date: 2015-03-20

Variant appearance in text: CALR: E380X

PubMed Link: 25794131

Variant Present in the following documents:

• Main text
• bcj201521a.pdf

View BVdb publication page